Vitruvian Partners LLP 13F holdings, Q4 2025
Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →
Vitruvian Partners LLP disclosed 7 US equity positions worth $139.2m in its Q4 2025 13F filing. The largest position was HNGE at 41.7% of the reported book, followed by MQ and CARG. Against the Q3 2025 filing, it opened 0 new positions, added to 2 and reduced 1 among the top 7 holdings.
What did Vitruvian Partners LLP own in Q4 2025? Top 7 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2025 |
|---|---|---|---|---|---|---|---|
| 1 | HNGE HINGE HEALTH INC | Healthcare | 41.7% | $58.1m | 1,250,000 | 0% | held |
| 2 | MQ MARQETA | Technology | 23.4% | $32.6m | 6,853,183 | 0% | held |
| 3 | CARG CARGURUS INC | Communication Services | 13.0% | $18.1m | 472,959 | 0% | held |
| 4 | XMTR XOMETRY INC | 8.2% | $11.4m | 191,919 | -19% | reduced | |
| 5 | GLBE GLOBAL-E | Consumer Cyclical | 5.9% | $8.3m | 210,209 | 22% | added |
| 6 | MXCT MAXCYTE | 5.6% | $7.8m | 5,043,356 | 0% | held | |
| 7 | RXST RXSIGHT | Healthcare | 2.1% | $2.9m | 278,865 | 21% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.